Recruiting
Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization
The objective of this observational pilot study is to collect HemoCept device data from subjects undergoing diagnostic right heart catheterization (RHC) procedures.
ClinicalTrials.gov IDNCT07224906
PhaseNot Applicable
Enrollment50
SponsorHemoCept Inc.
Age18 Years and older
SexALL
Conditions studied
Pulmonary Hypertension, Congestive Heart Failure(CHF), Valve Disease, Heart
About this study
The objective of this observational pilot study is to collect HemoCept device data from subjects undergoing diagnostic right heart catheterization (RHC) procedures.
Primary outcomes
- Association between device measurements and Pulmonary Capillary Wedge Pressure (Day 1)
Eligibility information
Inclusion Criteria:
* Subjects or representatives must have voluntarily signed the informed consent form before any study related procedures.
* Subjects can be any gender but must be age 18 or older.
* Subject is able and willing to provide informed consent and HIPAA authorization.
* Subject is able and willing to meet all study requirements.
* Scheduled for a diagnostic right heart catheterization (RHC-only or combined RHC+LHC; left-heart-only procedures are not eligible)
Exclusion Criteria:
* Subject is pregnant, breastfeeding, or intends to become pregnant during this study.
Study locations
- Boulder Heart, Boulder, Colorado 80303 United States
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-11-12.